Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7756488rdf:typepubmed:Citationlld:pubmed
pubmed-article:7756488lifeskim:mentionsumls-concept:C0001175lld:lifeskim
pubmed-article:7756488lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:7756488lifeskim:mentionsumls-concept:C0006837lld:lifeskim
pubmed-article:7756488lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:7756488lifeskim:mentionsumls-concept:C0226896lld:lifeskim
pubmed-article:7756488lifeskim:mentionsumls-concept:C0012854lld:lifeskim
pubmed-article:7756488lifeskim:mentionsumls-concept:C0016277lld:lifeskim
pubmed-article:7756488lifeskim:mentionsumls-concept:C0370215lld:lifeskim
pubmed-article:7756488lifeskim:mentionsumls-concept:C0449560lld:lifeskim
pubmed-article:7756488lifeskim:mentionsumls-concept:C0449435lld:lifeskim
pubmed-article:7756488pubmed:issue3lld:pubmed
pubmed-article:7756488pubmed:dateCreated1995-6-29lld:pubmed
pubmed-article:7756488pubmed:abstractTextSixty-two Candida albicans isolates from the oral cavities of 28 patients with AIDS who were receiving fluconazole therapy were typed by restriction endonuclease analysis followed by pulsed-field gel electrophoresis; these isolates were then tested for fluconazole susceptibility by a standard broth dilution method. Sequential isolates (range, 2-4) were evaluated for 22 patients; only one isolate was evaluated for six patients. DNA subtyping revealed a total of 37 different DNA subtypes. Twelve (54.5%) of 22 patients with multiple episodes of oropharyngeal candidiasis were infected with a single DNA subtype throughout the observation period. Ten (45.5%) of 22 patients with multiple episodes of oropharyngeal candidiasis were infected with two or three DNA subtypes during the observation period. In vitro susceptibility tests revealed that MICs of fluconazole ranged from < or = 0.125 microgram/mL to 64 micrograms/mL, with an MIC50 of 0.5 microgram/mL and an MIC90 of 4 micrograms/mL. A significant increase in the MICs (fourfold or greater) of fluconazole for sequential C. albicans isolates was found for 66.6% of the patients infected with a single DNA subtype and for 50% of the patients infected with multiple DNA subtypes. Despite a limited number of patients and isolates, our data suggest that C. albicans isolates that are susceptible to fluconazole at MICs of > or = 8 micrograms/mL in vitro will be less susceptible in vivo to standard doses (100-200 mg/d) of this drug.lld:pubmed
pubmed-article:7756488pubmed:languageenglld:pubmed
pubmed-article:7756488pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7756488pubmed:citationSubsetIMlld:pubmed
pubmed-article:7756488pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7756488pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7756488pubmed:statusMEDLINElld:pubmed
pubmed-article:7756488pubmed:monthMarlld:pubmed
pubmed-article:7756488pubmed:issn1058-4838lld:pubmed
pubmed-article:7756488pubmed:authorpubmed-author:ScaliseGGlld:pubmed
pubmed-article:7756488pubmed:authorpubmed-author:RinaldiM GMGlld:pubmed
pubmed-article:7756488pubmed:authorpubmed-author:PfallerM AMAlld:pubmed
pubmed-article:7756488pubmed:authorpubmed-author:BarchiesiFFlld:pubmed
pubmed-article:7756488pubmed:authorpubmed-author:McGoughD ADAlld:pubmed
pubmed-article:7756488pubmed:authorpubmed-author:HollisR JRJlld:pubmed
pubmed-article:7756488pubmed:issnTypePrintlld:pubmed
pubmed-article:7756488pubmed:volume20lld:pubmed
pubmed-article:7756488pubmed:ownerNLMlld:pubmed
pubmed-article:7756488pubmed:authorsCompleteYlld:pubmed
pubmed-article:7756488pubmed:pagination634-40lld:pubmed
pubmed-article:7756488pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7756488pubmed:meshHeadingpubmed-meshheading:7756488-...lld:pubmed
pubmed-article:7756488pubmed:meshHeadingpubmed-meshheading:7756488-...lld:pubmed
pubmed-article:7756488pubmed:meshHeadingpubmed-meshheading:7756488-...lld:pubmed
pubmed-article:7756488pubmed:meshHeadingpubmed-meshheading:7756488-...lld:pubmed
pubmed-article:7756488pubmed:meshHeadingpubmed-meshheading:7756488-...lld:pubmed
pubmed-article:7756488pubmed:meshHeadingpubmed-meshheading:7756488-...lld:pubmed
pubmed-article:7756488pubmed:meshHeadingpubmed-meshheading:7756488-...lld:pubmed
pubmed-article:7756488pubmed:meshHeadingpubmed-meshheading:7756488-...lld:pubmed
pubmed-article:7756488pubmed:meshHeadingpubmed-meshheading:7756488-...lld:pubmed
pubmed-article:7756488pubmed:meshHeadingpubmed-meshheading:7756488-...lld:pubmed
pubmed-article:7756488pubmed:year1995lld:pubmed
pubmed-article:7756488pubmed:articleTitleDNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS.lld:pubmed
pubmed-article:7756488pubmed:affiliationDepartment of Pathology, University of Texas Health Science Center, San Antonio 78284-7750, USA.lld:pubmed
pubmed-article:7756488pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7756488pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7756488lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7756488lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7756488lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7756488lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7756488lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7756488lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7756488lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7756488lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7756488lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7756488lld:pubmed